Search results
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 3 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
High school football coach unable to get chemo due to shortage dies: ‘Nothing else they could do’
The Today Show via AOL· 5 days agoThe chemotherapy shortage cut short Jeff Bolle's treatment for stage 4 bile duct cancer and he died....
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoThat RS Rating means Pfizer stock ranks in the bottom 16% of all stocks in terms of performance over...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 3 days agoSmaller companies may feel the brunt of the negative effects of this FDA initiative...when it comes...
Is It Too Late to Buy McDonald's Stock Now?
Motley Fool via Yahoo Finance· 7 days agoNow, this does present a risk that's worth mentioning. The franchisees are the ones who have to grapple with food and labor inflation. And in some...
‘Like wildfires underwater’: Worst summer on record for Great Barrier Reef as coral die-off sweeps...
WKBT La Crosse· 7 hours agoAs the early-morning sun rises over the Great Barrier Reef, its light pierces the turquoise waters of a shallow lagoon, bringing more than a dozen turtles to life. The Great Barrier Reef just ...
The family who turned Asheville into Beer City celebrates 30 years of business
Asheville Citizen-Times via Yahoo Finance· 4 days agoAshburn said the company has remained family-owned and operated and employs a local workforce...
Popular media site files Chapter 11 bankruptcy
TheStreet.com· 6 days agoWhen you hang your hat on denying the results of the 2020 election and supporting various other conspiracy theories, you place your business on tenuous legal grounds. Fox News famously supported ...
FDA approves Abbott's dissolving stent for leg artery disease By Investing.com
Investing.com· 5 days agoThe U.S. Food and Drug Administration has approved Abbott's Esprit BTK Everolimus Eluting Resorbable...
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
Char-Koosta News· 1 day agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases